Different types of COVID-19 vaccines: How they work

Different types of COVID-19 vaccines: How they work

Curious about how mRNA vaccines and other types of COVID-19 vaccines can help you develop immunity to the COVID-19 virus? Understand how different technologies work with the immune system to provide protection.

A coronavirus disease 2019 (COVID-19) vaccine can prevent you from getting COVID-19 or from becoming seriously ill or dying due to COVID-19. But how do the different types of COVID-19 vaccines work?

Each COVID-19 vaccine causes the immune system to create antibodies to fight COVID-19. COVID-19 vaccines use a harmless version of a spikelike structure on the surface of the COVID-19 virus called an S protein.

mRNA vaccine

Close

A mRNA vaccine is made using mRNA that gives your cells instructions for how to make the spike protein found on the surface of the COVID-19 virus. After vaccination, your immune cells begin making the spike protein and displaying them on cell surfaces. This causes your body to create antibodies that can fight the COVID-19 virus.

Viral vector vaccine

Close

A viral vector vaccine is made when genetic material from a COVID-19 virus is inserted into a unrelated, harmless virus. When the viral vector gets into your cells, it delivers genetic material from the COVID-19 virus that gives your cells instructions for how to make the spike protein found on the surface of the COVID-19 virus. Once your cells displace the spike proteins on their surfaces, your immune system creates antibodies that can fight the COVID-19 virus.

Protein subunit vaccine

Close

Subunit vaccines include only the parts of a virus that best stimulate your immune system. This type of COVID-19 vaccine contains harmless S proteins. Once your immune system recognizes the S proteins, it creates antibodies and defensive white blood cells. If you later become infected with the COVID-19 virus, the antibodies will fight the virus.

The main types of COVID-19 vaccines currently available in the U.S. or being studied include:

Messenger RNA (mRNA) vaccine. This type of vaccine gives your cells instructions for how to make the S protein found on the surface of the COVID-19 virus. After vaccination, your muscle cells begin making the S protein pieces and displaying them on cell surfaces. This causes your body to create antibodies. If you later become infected with the COVID-19 virus, these antibodies will fight the virus.

Once the protein pieces are made, the cells break down the instructions and get rid of them. The mRNA in the vaccine doesnt enter the nucleus of the cell, where DNA is kept. Both the Pfizer-BioNTech and the Moderna COVID-19 vaccines use mRNA.

Vector vaccine. In this type of vaccine, material from the COVID-19 virus is placed in a modified version of a different virus (viral vector). The viral vector gives your cells instructions to make copies of the COVID-19 S protein. Once your cells display the S proteins on their surfaces, your immune system responds by creating antibodies and defensive white blood cells. If you later become infected with the COVID-19 virus, the antibodies will fight the virus.

Viral vector vaccines can't cause you to become infected with the COVID-19 virus or the viral vector virus. The Janssen/Johnson & Johnson COVID-19 vaccine is a vector vaccine. AstraZeneca and the University of Oxford also have a vector COVID-19 vaccine.

Protein subunit vaccine. Subunit vaccines include only the parts of a virus that best stimulate your immune system. This type of COVID-19 vaccine contains harmless S proteins. Once your immune system recognizes the S proteins, it creates antibodies and defensive white blood cells. If you later become infected with the COVID-19 virus, the antibodies will fight the virus.

The Novavax COVID-19 vaccine is a protein subunit vaccine.

The U.S. Food and Drug Administration (FDA) has approved the Pfizer-BioNTech COVID-19 vaccine, now called Comirnaty, to prevent COVID-19 in people age 12 and older. The vaccine is under an emergency use authorization for children age 6 months through age 11. The FDA has also approved the Moderna vaccine, now called Spikevax, to prevent COVID-19 in people age 18 and older. The FDA has given emergency use authorization to Moderna COVID-19 vaccines for age 6 months to age 17. The FDA has given emergency use authorization to the Janssen/Johnson & Johnson COVID-19 vaccine for certain people age 18 and older. The FDA has also given emergency use authorization to the Novavax COVID-19, adjuvanted vaccine for people age 12 and older.

Sign up for free, and stay up to date on research advancements, health tips and current health topics, like COVID-19, plus expertise on managing health. Click here for an email preview.

To provide you with the most relevant and helpful information, and understand which information is beneficial, we may combine your email and website usage information with other information we have about you. If you are a Mayo Clinic patient, this could include protected health information. If we combine this information with your protected health information, we will treat all of that information as protected health information and will only use or disclose that information as set forth in our notice of privacy practices. You may opt-out of email communications at any time by clicking on the unsubscribe link in the e-mail.

Subscribe!

You'll soon start receiving the latest Mayo Clinic health information you requested in your inbox.

Please, try again in a couple of minutes

Retry

.

Read more from the original source:

Different types of COVID-19 vaccines: How they work